Institutional Ownership
Bridgebio Pharma Inc
CUSIP 10806XAB8NOTE 2.500% 3/1BBIOQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boussard & Gavaudan Investment Management LLP | 26.0K | $46.24M |
| 2 | State Of Wisconsin Investment Board | 3.00M | $5.39M |
| 3 | Nomura Holdings Inc | 28.1K | $2.09M |
| 4 | Ssi Investment Management LLC | 398.0K | $715.6K |
| 5 | Traub Capital Management LLC | 10.0K | $18.0K |
| 6 | Northwestern Mutual Wealth Management Co | 1.0K | $1.8K |
| 7 | Jones Financial Companies Lllp | 1.0K | $1.7K |